Skip to main content
Samuel Gandy, MD, Neurology, New York, NY

SamuelE.GandyMDPhD

Neurology New York, NY

Neurodegenerative, Dementia & Geriatrics

Professor of Neurology and Psychiatry Director, Center for Cognitive Health

Dr. Gandy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gandy's full profile

Already have an account?

  • Office

    5 E 98th St # 1139
    7th Floor
    New York, NY 10029
    Phone+1 212-241-7076
    Fax+1 212-860-4952

Summary

  • Dr. Sam Gandy is a neurologist in New York, NY, affiliated with Mount Sinai and the James J. Peters Veterans Affairs Medical Center. He received his MD and PhD degrees from Medical University of South Carolina and has been in practice 42 years. He has published over 300 original research papers and reviews. He has been continuously funded by the NIH since 1986. His h index is 95.
  • 'I'm still here': Before Alzheimer's, he prided himself on his intellect

    Tony Downs is taking Leqembi to forestall the progression of early-onset Alzheimers. The Boston Globe spoke with Downs and his wife over several months.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1983 - 1986
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1982 - 1983
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 1982
  • Charleston Southern University
    Charleston Southern UniversityB.S., Summa Cum Laude, 1976

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • NY State Medical License
    NY State Medical License 1983 - 2026
  • GA State Medical License
    GA State Medical License 2007 - 2008
  • PA State Medical License
    PA State Medical License 2002 - 2008
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Visiting Principal Research Fellow South Australia Health and Medical Research Institute, 2014
  • Arthur Cherkin Memorial Award in Geriatric Medicine University of California, Los Angeles, 2008
  • Alpha Omega Alpha 1981

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women  
    Bates KA, Sohrabi HR, Rainey-Smith SR, Weinborn M, Bucks RS, Rodrigues M, Beilby J, Howard M, Taddei K, Martins G, Paton A, Shah T, Dhaliwal SS, Foster JK, Martins IJ,..., Int J Neurosci, 1/1/2017
  • Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCA...  
    Ruiz HH, Chi T, Shin AC, Lindtner C, Hsieh W, Ehrlich M, Gandy S, Buettner C, Alzheimers Dement, 1/1/2016
  • Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer'srelated Sorcs1  
    Knight EM, Ruiz HH, Kim SH, Harte JC, Hsieh W, Glabe C, Klein WL, Attie AD, Buettner C, Ehrlich ME, Gandy S, Acta Neuropathol Commun, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Scientific Foundations of Clinical Medicine, Dementia Module 
    1/1/2007
  • Molecular Basis of Neurological Disease 
    1/1/2006

Press Mentions

  • Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
    Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of DiseaseMay 4th, 2023
  • Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Disease Progress
    Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Disease ProgressMay 3rd, 2023
  • A Neurologist Answers Questions Patients Might Have About the New Alzheimer’s Drug Lecanemab
    A Neurologist Answers Questions Patients Might Have About the New Alzheimer’s Drug LecanemabJanuary 27th, 2023
  • Join now to see all

Grant Support

  • Alzheimer Mouse Model For Intraneuronal Amyloid-Beta Oligomer BiologyVeterans Affairs2011–2012
  • Evidence For Gamma-Secretase Dysfunction In Sporadic ADNational Institute On Aging2010–2012
  • Phase 11-Grape Seed Extract As Anti-Oligomerization Agent In Alzheimer'S DiseaseNational Center For Complementary &Alternative Medicine2010
  • Lipoproteins, Signal Transduction, And Activation Of APP Ectodomain SheddingNational Institute On Aging2007–2009
  • Interdisciplinary Approach To Alzheimer Drug DiscoveryNational Institute On Aging2007–2009
  • Presenilin Domains And Reconstitution Of CatalysisNational Institute On Aging2007
  • Presenilin Domains And Reconstitution Of CatalysisNational Institute On Aging2005–2006
  • Lipoproteins, Signal Transduction, Activation Of APP ECTNational Institute On Aging2005–2006
  • Interdisciplinary Approach To Alzheimer Drug DiscoveryNational Institute On Aging2002–2006
  • Administrative CoreNational Institute On Aging2005
  • Estrogen Modulation Of Brain Abeta Metabolism In VivoNational Institute Of Neurological Disorders And Stroke2002–2004
  • Transmitter Neuroanatomy In Alzheimers DiseaseNational Institute On Aging2002
  • Babaa Receptors In Aging &Alzheimer'S DiseaseNational Institute On Aging2002
  • Estrogen Modulation Of Brain Abeta Metabolism In VivoNational Institute Of Neurological Disorders And Stroke2001–2002
  • Protein Protein Interactions In Amyloid Beta MetabolismNational Institute On Aging2000–2002
  • Interdisciplinary Approach To Alzheimer Drug DiscoveryNational Institute On Aging2000–2001
  • Cell Biological Studies Of Amyloid Precursor ProteinNational Institute On Aging1996–2000
  • Generation &Regulation Of Amyloid Peptide Variants By Neurons: AlzheimerNational Center For Research Resources1999
  • Estrogen Reduces Neuronal Generation Of Alzheimer Amyloid Peptides LENational Center For Research Resources1999
  • Regulated Cleavage Of Amyloid Precursor--Molecular BasisNational Institute On Aging1996–1997
  • Molecular Cell Biology Of Alzheimer AmyloidogenesisNational Institute On Aging1995
  • Signal Transduction &Alzheimer'S Disease--Cell Biological StudiesNational Institute On Aging1991–1995
  • Molecular Cell Biology Of Alzheimer AmyloidogenesisNational Institute On Aging1992–1994
  • Cell Biology Of Amyloid Precursor Protein Processing In Vitro, In VivoNational Institute On Aging1991–1994
  • Regulation Of Amyloid Formation In Alzheimers DiseaseNational Center For Research Resources1991
  • Characterization Of A Neuron-Specific PhosphoproteinNational Institute Of Neurological Disorders And Stroke1986–1990

Professional Memberships

Other Languages

  • Spanish, Korean, Japanese